Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S A Mitchell

Showing results (71-80 of 99) with videos related to

Pageof 10
Sort By:
International Journal of Peptide and Protein Research|September 1, 1995
D-enantiomers of 15-residue cecropin A-melittin hybridsE L Merrifield, S A Mitchell, J Ubach, et al.
Plos One|September 16, 2016
Correction: Comparison of the Non-VKA Oral Anticoagulants Apixaban, Dabigatran, and Rivaroxaban in the Extended Treatment and Prevention of Venous Thromboembolism: Systematic Review and Network Meta-AnalysisA T Cohen, M Hamilton, A Bird, et al.
Plos One|August 4, 2016
Comparison of the Non-VKA Oral Anticoagulants Apixaban, Dabigatran, and Rivaroxaban in the Extended Treatment and Prevention of Venous Thromboembolism: Systematic Review and Network Meta-AnalysisA T Cohen, M Hamilton, A Bird, et al.
The Journal of Hospital Infection|April 16, 2017
Impact of surgical site infection on healthcare costs and patient outcomes: a systematic review in six European countriesJ M Badia, A L Casey, N Petrosillo, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 21, 2001
Improved blood-brain barrier penetration and enhanced analgesia of an opioid peptide by glycosylationR D Egleton, S A Mitchell, J D Huber, et al.
Gut|September 18, 2002
Cigarette smoking, appendectomy, and tonsillectomy as risk factors for the development of primary sclerosing cholangitis: a case control studyS A Mitchell, M Thyssen, T R Orchard, et al.
Gastroenterology|October 19, 2001
A preliminary trial of high-dose ursodeoxycholic acid in primary sclerosing cholangitisS A Mitchell, D S Bansi, N Hunt, et al.
International Journal of Peptide and Protein Research|November 1, 1992
Antibacterial peptides designed as analogs or hybrids of cecropins and melittinD Wade, D Andreu, S A Mitchell, et al.
Plos One|December 31, 2015
Comparison of the Novel Oral Anticoagulants Apixaban, Dabigatran, Edoxaban, and Rivaroxaban in the Initial and Long-Term Treatment and Prevention of Venous Thromboembolism: Systematic Review and Network Meta-AnalysisA T Cohen, M Hamilton, S A Mitchell, et al.
Biomaterials|March 30, 2004
Cellular attachment and spatial control of cells using micro-patterned ultra-violet/ozone treatment in serum enriched mediaS A Mitchell, A H C Poulsson, M R Davidson, et al.
Pageof 10

Showing results (71-80 of 99) with videos related to

Sort By:
Pageof 10
International Journal of Peptide and Protein Research|September 1, 1995
D-enantiomers of 15-residue cecropin A-melittin hybridsE L Merrifield, S A Mitchell, J Ubach, et al.
Plos One|September 16, 2016
Correction: Comparison of the Non-VKA Oral Anticoagulants Apixaban, Dabigatran, and Rivaroxaban in the Extended Treatment and Prevention of Venous Thromboembolism: Systematic Review and Network Meta-AnalysisA T Cohen, M Hamilton, A Bird, et al.
Plos One|August 4, 2016
Comparison of the Non-VKA Oral Anticoagulants Apixaban, Dabigatran, and Rivaroxaban in the Extended Treatment and Prevention of Venous Thromboembolism: Systematic Review and Network Meta-AnalysisA T Cohen, M Hamilton, A Bird, et al.
The Journal of Hospital Infection|April 16, 2017
Impact of surgical site infection on healthcare costs and patient outcomes: a systematic review in six European countriesJ M Badia, A L Casey, N Petrosillo, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 21, 2001
Improved blood-brain barrier penetration and enhanced analgesia of an opioid peptide by glycosylationR D Egleton, S A Mitchell, J D Huber, et al.
Gut|September 18, 2002
Cigarette smoking, appendectomy, and tonsillectomy as risk factors for the development of primary sclerosing cholangitis: a case control studyS A Mitchell, M Thyssen, T R Orchard, et al.
Gastroenterology|October 19, 2001
A preliminary trial of high-dose ursodeoxycholic acid in primary sclerosing cholangitisS A Mitchell, D S Bansi, N Hunt, et al.
International Journal of Peptide and Protein Research|November 1, 1992
Antibacterial peptides designed as analogs or hybrids of cecropins and melittinD Wade, D Andreu, S A Mitchell, et al.
Plos One|December 31, 2015
Comparison of the Novel Oral Anticoagulants Apixaban, Dabigatran, Edoxaban, and Rivaroxaban in the Initial and Long-Term Treatment and Prevention of Venous Thromboembolism: Systematic Review and Network Meta-AnalysisA T Cohen, M Hamilton, S A Mitchell, et al.
Biomaterials|March 30, 2004
Cellular attachment and spatial control of cells using micro-patterned ultra-violet/ozone treatment in serum enriched mediaS A Mitchell, A H C Poulsson, M R Davidson, et al.
Pageof 10